Clinical Trial Update: Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study [NA]

View source ↗

Summary

Clinical trial update on selective implantation of the Zephyr EBV for COPD with homogeneous emphysema; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Zephyr Endobronchial Valve (endobronchial valve)

Snippet

Sponsor: Pulmonx International Sàrl | Conditions: COPD Patients With Homogeneous Emphysema, Endoscopic Lung Volume Reduction With Endobronchial Valve | NA | Status: COMPLETED | Results posted: 2019-08-16